Liver Disorders Caused by Inborn Errors of Metabolism

被引:2
作者
Vakili, Omid [1 ]
Mafi, Alireza [1 ]
Pourfarzam, Morteza [1 ,2 ,3 ,4 ]
机构
[1] Isfahan Univ Med Sci, Dept Clin Biochem, Sch Pharm & Pharmaceut Sci, Esfahan, Iran
[2] Isfahan Univ Med Sci, Bioinformat Res Ctr, Sch Pharm & Pharmaceut Sci, Esfahan, Iran
[3] Isfahan Univ Med Sci, Dept Clin Biochem, Esfahan, Iran
[4] Isfahan Univ Med Sci, Bioinformat Res Ctr, Sch Pharm & Pharmaceut Sci, Esfahan, Iran
关键词
Inborn errors of metabolism; cholestasis; obstructive jaundice; hepatosplenomegaly; liver failure; hepatic dysfunction; FATTY-ACID OXIDATION; LYSOSOMAL STORAGE DISORDERS; TYROSINEMIA TYPE-I; CONGENITAL ERYTHROPOIETIC PORPHYRIA; RESPIRATORY-CHAIN DISORDERS; UREA CYCLE DISORDERS; ALPHA-1-ANTITRYPSIN DEFICIENCY; ALPHA(1)-ANTITRYPSIN DEFICIENCY; FUMARYLACETOACETATE HYDROLASE; MOLECULAR-BASIS;
D O I
10.2174/1871530323666230623120935
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inborn errors of metabolism (IEMs) are a vast array of inherited/congenital disorders, affecting a wide variety of metabolic pathways and/or biochemical processes inside the cells. Although IEMs are usually rare, they can be represented as serious health problems. During the neonatal period, these inherited defects can give rise to almost all key signs of liver malfunction, including jaundice, coagulopathy, hepato- and splenomegaly, ascites, etc. Since the liver is a vital organ with multiple synthetic, metabolic, and excretory functions, IEM-related hepatic dysfunction could seriously be considered life-threatening. In this context, the identification of those hepatic manifestations and their associated characteristics may promote the differential diagnosis of IEMs immediately after birth, making therapeutic strategies more successful in preventing the occurrence of subsequent events. Among all possible liver defects caused by IEMs, cholestatic jaundice, hepatosplenomegaly, and liver failure have been shown to be manifested more frequently. Therefore, the current study aims to review substantial IEMs that mostly result in the aforementioned hepatic disorders, relying on clinical principles, especially through the first years of life. In this article, a group of uncommon hepatic manifestations linked to IEMs is also discussed in brief.
引用
收藏
页码:194 / 207
页数:14
相关论文
共 119 条
  • [41] Screening for lysosomal storage disorders - A clinical perspective
    Fletcher, Janice M.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (2-3) : 405 - 408
  • [42] Urea cycle disorders: A case report of a successful treatment with liver transplant and a literature review
    Foschi, Francesco Giuseppe
    Morelli, Maria Cristina
    Savini, Sara
    Dall'Aglio, Anna Chiara
    Lanzi, Arianna
    Cescon, Matteo
    Ercolani, Giorgio
    Cucchetti, Alessandro
    Pinna, Antonio Daniele
    Stefanini, Giuseppe Francesco
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 4063 - 4068
  • [43] Hereditary alpha-I-antitrypsin deficiency and its clinical consequences
    Fregonese, Laura
    Stolk, Jan
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2008, 3 (1)
  • [44] Garrod AE, 1908, LANCET, V2, P1
  • [45] Neonatal cholestasis - differential diagnoses, current diagnostic procedures, and treatment
    Goetze, Thomas
    Blessing, Holger
    Grillhoesl, Christian
    Gerner, Patrick
    Hoerning, Andre
    [J]. FRONTIERS IN PEDIATRICS, 2015, 3
  • [46] Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood
    Gonzales, Emmanuel
    Matarazzo, Lorenza
    Franchi-Abella, Stephanie
    Dabadie, Alain
    Cohen, Joseph
    Habes, Dalila
    Hillaire, Sophie
    Guettier, Catherine
    Taburet, Anne-Marie
    Myara, Anne
    Jacquemin, Emmanuel
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [47] Oral Cholic Acid for Hereditary Defects of Primary Bile Acid Synthesis: A Safe and Effective Long-term Therapy
    Gonzales, Emmanuel
    Gerhardt, Marie F.
    Fabre, Monique
    Setchell, Kenneth D. R.
    Davit-Spraul, Anne
    Vincent, Isabelle
    Heubi, James E.
    Bernard, Olivier
    Jacquemin, Emmanuel
    [J]. GASTROENTEROLOGY, 2009, 137 (04) : 1310 - 1320
  • [48] The molecular and cellular pathology of α1-antitrypsin deficiency
    Gooptu, Bibek
    Dickens, Jennifer A.
    Lomas, David A.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2014, 20 (02) : 116 - 127
  • [49] European screening for alpha1-antitrypsin deficiency in subjects with lung disease
    Greulich, Timm
    Averyanov, Alexander
    Borsa, Ludmila
    Rozborilova, Eva
    Vaicius, Dalius
    Major, Tamas
    Chopyak, Valentyna
    Tudorache, Voicu
    Konstantinova, Tatyana
    Camprubi, Sandra
    [J]. CLINICAL RESPIRATORY JOURNAL, 2017, 11 (01) : 90 - 97
  • [50] Gruntman AM, 2017, METHODS MOL BIOL, V1639, P267, DOI 10.1007/978-1-4939-7163-3_27